Boyds
Monica Pianella currently serves as Associate Director of Regulatory Affairs at Boyds since November 2023, following a tenure as Senior Regulatory Affairs Manager at Cell and Gene Therapy Catapult from January 2020 to October 2023. Monica's experience encompasses strategic planning, regulatory submissions, and project management for advanced therapies, alongside providing mentorship and guidance to regulatory team members. Previous roles include regulatory affairs positions focused on CMC documentation and project support at GSK, where Monica contributed to innovative formulations for T-cell therapies, and involvement with the MHRA British Pharmacopoeia in developing best practice documents for advanced therapies. Monica holds a Master of Science in Pharmaceutical Chemistry and Technology from Sapienza Università di Roma and has completed research at both the University of Rome "La Sapienza" and the University of Rhode Island.
This person is not in any offices
Boyds
At Boyds, our goal is to facilitate the translation of cutting-edge science into medicinal products which benefit patients. We understand how challenging this can be, both technically and commercially. Our service is designed to provide crucial experience and assistance whenever you need it, in order to bring your innovations to the marketplace as quickly and efficiently as possible. Boyds was established in 2005 and provides a range of expertise and skills central to the development of pharmaceutical and biotechnology medicinal products and medical devices. We are headquartered in the UK with offices located in Cheshire and Cambridgeshire and also have offices in Dublin and Pennsylvania. Our consultancy services offer a cost-effective solution for those requiring expert assistance in order to expedite development, add value to their product, and reach those key milestones. Whether it relates to a single issue or a long-term commitment to your development team, we can help you chart the innovative course great science demands.